Monday, December 23, 2024 | 02:41 AM ISTEN Hindi

Home / Content / B2B Connect / Pharma / Fujifilm expands biopharma facilities in US & UK with $ 130 mn investment

Fujifilm expands biopharma facilities in US & UK with $ 130 mn investment

The company's new process development facilities to support growing market of biopharmaceuticals

Premium

Fujifilm Diosynth Biotechnologies facility

BS B2B Bureau Tokyo, Japan

Last Updated : Apr 24 2017 | 1:12 PM IST

Fujifilm Corporation will invest about Yen 14 billion ($ 130 million) for increasing the production capacity in the US and UK to expand the business of its BioCDMO division, which focuses on contract development & manufacturing for biologics.

In the US, at Fujifilm Diosynth Biotechnologies (FDB), has already invested JPY 10 billion ($ 93 million) - a part of which was funded by BARDA (Biomedical Advanced Research and Development Authority), an office of the US Department of Health and Human Services - for setting up a production facility in Texas (USA).

In addition to this, Fujifilm now plans to invest Yen 3

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in